Altered hippocampal synaptic potentiation in P2X(4) knock-out mice by Sim, Joan A. et al.
Brief Communications
Altered Hippocampal Synaptic Potentiation in P2X4
Knock-Out Mice
Joan A. Sim,1 Se´verine Chaumont,2 Jihoon Jo,3 Lauriane Ulmann,2Mark T. Young,1 Kwangwook Cho,3 Gary Buell,4
R. Alan North,1 and Francois Rassendren2
1Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom, 2Department of Molecular Pharmacology, Centre National de la
Recherche Scientifique, Unite´ Mixte de Recherche 5203, Institut National de la Sante´ et de la Recherche Me´dicale, Unite´ 661, Universite´s Montpellier 1 et 2,
Montpelier 34396, France, 3Department of Biomedical Sciences, University of Sheffield, Sheffield S10 2TN, United Kingdom, and 4GlaxoWellcome
Biomedical Research Institute, Plan-les-Ouates, Geneva 1228, Switzerland
P2X4 purinergic receptors are calcium-permeable, ATP-activated ion channels. In the CA1 area of the hippocampus, they are located at
the subsynapticmembrane somewhat peripherally to AMPA receptors. The possible role of P2X4 receptors has been difficult to elucidate
because of the lack of selective antagonists. Here we report the generation of a P2X4 receptor knock-out mouse and show that long-term
potentiation (LTP) at Schaffer collateral synapses is reduced relative to that in wild-type mice. Ivermectin, which selectively potentiates
currents at P2X4 , was found to increase LTP in wild-type mice but had no effect in P2X4 knock-out mice. We suggest that calcium entry
through subsynaptic P2X4 receptors during high-frequency stimulation contributes to synaptic strengthening.
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Introduction
P2X4 purinergic receptors are widely distributed throughout the
CNS (Buell et al., 1996; Collo et al., 1996; Se´gue´la et al., 1996; Soto
et al., 1996). Immunogold electronmicroscopy shows that, in the
CA1 region of the hippocampus, they have a perisynaptic loca-
tion on postsynaptic membranes apposed to terminals of Schaf-
fer collaterals (Rubio and Soto, 2001). P2X4 receptors have a
relatively high permeability to calcium (PCa/PNa 4) (Soto et al.,
1996; North, 2002; Egan and Khakh, 2004); therefore, any ATP
released at these synapsesmight contribute to changes in synaptic
strength during repetitive activity. It is well known that long-
lasting changes in synaptic strength can be induced at these syn-
apses by calcium entering through NMDA receptors (Bliss and
Collingridge, 1993; Malenka and Nicoll, 1993).
Involvement of P2X4 receptors in hippocampal synaptic
transmission has been difficult to test experimentally because of
the lack of effective antagonists (Buell et al., 1996; North and
Surprenant, 2000; North, 2002). A role for P2X receptors in gen-
eral was inferred from one study (Pankratov et al., 2002): in this
case, a brief (0.2 s) high-frequency stimulation that did not nor-
mally elicit long-term potentiation (LTP) was able to do so after
application of the antagonist pyridoxal-phophate-6-axophenyl-
2,4-disulphonic acid (PPADS) (20 M). This action of PPADS
seems unlikely to result from block of P2X4 receptors because, at
least in the rat, they are quite insensitive to this antagonist (Buell
et al., 1996; North and Surprenant, 2000; North, 2002); it may act
by blocking different P2X receptors (e.g., P2X2 or P2X6) or other
receptors.
Ivermectin is an antifilarial drug that is becoming an increas-
ingly useful tool in the study of P2X4 receptors. It potentiates
ATP-induced currents at P2X4 receptors but not at other P2X
receptors (Khakh et al., 1999; Priel and Silberberg, 2004). How-
ever, ivermectin has actions on other ion channels (e.g., mouse
GABAA receptors, Krusek and Zemkova´, 1994; human 7 nico-
tinic receptors, Krause et al., 1998), and this has limited confi-
dence in the interpretation of its actions. The paucity of toolswith
which to probe the P2X4 receptor function led us to generate a
P2X4 knock-out mouse, so that hippocampal synaptic transmis-
sion could be compared between wild-type and knock-out ani-
mals.We argued that any effect of ivermectin that is present in the
wild-type but lacking in the knock-outmice should indicate P2X4
receptor involvement.
Materials andMethods
Generation of P2X4 receptor-deficient mice.Mice carrying a targeted null
mutation of the P2X4 gene were generated according to published pro-
tocols (Conquet, 1995). A 10 kb genomic DNA containing the first two
exons of the P2X4 subunit was isolated from a genomic library obtained
from 129/Sv mice. The targeting vector was constructed by the insertion
of a LacZ neomycin cassette, between a BgIII site located 30 bases up-
stream of P2X4-initiating methionine and a BamHI site 172 bases down-
streamof the first exon/intron boundary. This also resulted in a 337 bases
deletion encompassing the first exon (including P2X4-initiating methio-
nine) and 172 bases of the downstream intron (Fig. 1A). Embryonic stem
cells were cultured, transfected, and screened using standard methods.
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Targeted embryonic stem cells and mice carrying the mutant allele were
identified by Southern blotting (Fig. 1B), using a probe specific to a
genomic region upstream of the targeted locus as indicated in Figure 1A.
Germ-line chimeras were crossed with C57BL/6J to generate heterozy-
gotes and then backcrossed15 times onto the C57BL/6J strain.
Adult (25–60 d)male homozygotes and their correspondingwild-type
C57BL/6J mice were used in Western blotting and immunocytochemis-
try. Young adult mice (21–26 d) were used for electrophysiological stud-
ies. All procedures were performed according to United KingdomHome
Office legislation.
Immunocytochemistry and LacZ staining. Immunocytochemistry using
nickel–diaminobenzidine tetrahydrochloride chromagen with glucose
oxidase was performed as described previously (Sim et al., 2004). The
primary antibody used was polyclonal P2X4 antibody (1:1000 dilution)
from Alomone Labs (Jerusalem, Israel) and goat anti-rabbit peroxidase-
conjugated secondary antibody from Vector Laboratories (Peterbor-
ough, UK). Controls comprised the omission of the primary antibodies
from the immunostaining protocol and the use of P2X4 antibodies
preadsorbed with the corresponding peptide. -Galactosidase staining
was as described previously (Sim et al., 2004). After mounting, sections
were viewed using an Axiovert 25microscope, and images were acquired
using Zeiss (Oberkochen, Germany) Axiocam digital camera with Axio-
Vision software. For immunofluorescence, free-floating sections were
incubated in blocking solution (0.01% Triton X-100 and 10% FCS) for
30 min at room temperature and then incubated overnight at 4°C with a
home-produced rabbit antibody raised against the mouse P2X4 receptor
terminal peptide (1:500 dilution). After three washes in PBS, sections
were incubated for 2 h with goat-anti rabbit Alexa488 secondary anti-
body (Invitrogen, Carlsbad, CA). Sections were mounted and viewed
with a Leica (Nussloch, Germany) DMRA2 fluorescent microscope. Im-
ages were acquired using a cool-snap HQ (PhotoMetrics, Huntington
Beach, CA) digital camera controlled by the Metaview software suite.
Western blotting.Mice were killed by isoflurane anesthesia. The brain
and submandibular gland were removed; membrane fractions were pre-
pared and used for Western blotting as described previously (Sim et al.,
2004). The primary antibody was anti-rat P2X4 polyclonal antibody (1:
5000 dilution; Alomone Labs) and the goat anti-rabbit HRP-conjugated
secondary antibody (1:2000; DakoCytomation, Ely, UK). Positive con-
trols weremembrane fractions fromHEK293 cells transiently transfected
with mouse P2X4 receptors.
Electrophysiology. The brain was rapidly removed and placed in ice-
cold artificial CSF (aCSF) containing the following (in mM): 124 NaCl, 3
KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgSO4, 10 D-glucose, and
0.1 picrotoxin (bubbledwith 95%O2/5%CO2). Transverse hippocampal
slices (400 m thick) were prepared using a vibroslice (Leica). Hip-
pocampal slices were stored in aCSF (20–25°C) for 1–2 h before trans-
ferring to the recording chamber, in which they were submerged in aCSF
(30°C) flowing at  2 ml/min. Extracellular field potentials were re-
corded in the CA1 region using glass electrodes containing NaCl (4 M). A
stimulating electrode in CA2 was used to evoke EPSPs (constant voltage,
100 s duration, repeated at 30 s intervals). Long-term potentiation was
evoked by four trains of stimuli (each 100 Hz, 1 s; repeated at 15 s
intervals). The amplitude of the evoked field potential responses was
measured and expressed relative to the normalized preconditioning
baseline. Experiments in which changes in the fiber volley occurred were
discarded.
Data were recorded using an Axoclamp 2B amplifier (Molecular De-
vices, Palo Alto, CA), monitored, analyzed on-line, and reanalyzed off-
line (Anderson and Collingridge, 2001). Data were used from only one
slice per mouse. Data pooled across slices are expressed as the mean 
SEM, and effects of conditioning stimulation were measured between 45
and 50 min after tetanus stimuli. The significance of difference from
baseline was tested using two-tailed t tests.
Results
Western blotting showed that the P2X4 receptor protein was
completely absent from the brain, lung, and submandibular
gland of the knock-out P2X4
/ mice (Fig. 1C). Immunocyto-
chemistry showed the presence of P2X4 receptors in the hip-
pocampus of wild-type mice (Fig. 2A,C,E) that were not detect-
able in knock-out animals (Fig. 2B,D,F). The P2X4
immunoreactivity obvious inmany other parts of the brain, such
as Purkinje neurons (Fig. 2 I) and in submandibular glands (Fig.
2L), was completely absent in P2X4
/ mice (Fig. 2 J,M). Con-
versely, the P2X4
/ mouse showed strong staining of
-galactosidase in hippocampus (Fig. 2G), cerebellum (Fig. 2K),
and submandibular glands (Fig. 2N). The distribution of
-galactosidase staining in the brain of P2X4
/ mice mapped
well onto that reported previously for P2X4 receptor immunore-
activity (Leˆ et al., 1998; Rubio and Soto, 2001).
EPSPs were recorded extracellularly from the CA1 area of the
hippocampus in slices from knock-out P2X4
/ or wild-type
P2X4
/mice. Stimulation of the Schaffer collaterals (four trains
of 100 Hz for 1 s, at 15 s intervals) resulted in a sustained increase
in the amplitude of the field EPSP. The magnitude of LTP was
greater in wild-type P2X4
/ (169 4%of baseline; n 12) than
in knock-out P2X4
/mice (136 4% of baseline; n 12) (Fig.
3A); this difference was significant ( p	 0.001; n 12).
LTP was greater in hippocampal slices from wild-type
P2X4
/ mice that had been treated with ivermectin (3 M)
(213 9%; n 15) (Fig. 3C). However, ivermectin had no effect
on the magnitude of LTP recorded from knock-out P2X4
/
mice (138  2%; n  15) (Fig. 3D). Together, these findings
strongly suggest that ivermectin is exerting its effect by potenti-
Figure 1. Targeted disruption of themouse P2X4 gene.A, Maps of the P2X4wild-type allele,
targeting vector, and mutant allele. Boxes represent open reading frames; LacZ gene insertion
upstream of the P2X4-initiating methionine resulted in the deletion of all the coding region of
exon 1 and of the first exon–intron splice site. TK, Thymidine kinase; NEO, neomycin; Ex1, exon
1; B, BamH1; Bg, BgIII; S, SacI; X, XbaI. Southern blotting probe was designed outside of the
targeting locus between 5 SacI and XbaI sites. As shown, after digestion with SacI, this probe
will hybridize to a 5 or 10 kb DNA fragment for wild-type and mutant allele, respectively. B,
Southern blot analysis of genomic DNA digestedwith SacI from/,/, and/mice
using the probe described in A. C, Western blot of membrane protein fraction from brain, lung,
and submandibular gland of wild-type P2X4
/mice showed a band at 60 kDa, similar to that
observed inP2X4-expressingHEK293cells.Nobandof equivalent sizewasobserved fromknock-
out P2X4
/mice.
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ating field EPSPs through P2X4 receptors.
Ivermectin did not introduce an NMDA
receptor-independent form of long-term
synaptic plasticity because, in the presence
of ivermectin, the LTP in wild-type mice
was completely blocked by the NMDA an-
tagonist D-()-2-amino-5-phosphono-
pentanoic acid (50 M) (105 8%; n 4;
data not shown). Therefore, ivermectin
may act by increasing the activity of P2X4
receptors in the postsynaptic membrane
(Toulme´ et al., 2006).
Discussion
In certain experimental conditions, it can
be shown that a component of the EPSC in
hippocampal CA1 neurons is actually me-
diated by ATP (Pankratov et al., 1998).
However, the proportion of the total cur-
rent is rather small, as judged by the frac-
tion remaining after blockade of different
types of glutamate receptor (	10%), and
the functional significance is therefore un-
clear. Our observation that ivermectin did
not alter the field EPSP under resting con-
ditions would be consistent with such a
minor role. However, P2X4 receptors have
very substantial calcium permeability
(Soto et al., 1996; North, 2002; Egan and
Khakh, 2004), and, unlike NMDA recep-
tors, they are not subject to block by mag-
nesium at resting potentials. The results
with ivermectin, most strikingly its lack of
effect in the P2X4
/ knock-out mouse,
lead us to hypothesize that sufficient cal-
cium, which enters through perisynaptic
P2X4 receptors, is able to fine-tune the
NMDA-dependent component of long-
term synaptic plasticity of hippocampal
CA1 neurons. Additional studies will be
necessary to elucidate the details of the cel-
lular elements primarily involved, but
ivermectin and P2X4
/ knock-out mice
will be useful tools in that endeavor.
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(E; n 12; p	 0.001). B, LTP is enhanced by ivermectin (3M; F) in wild-type P2X4
/
mice but not in knock-out P2X4
/ mice (C) (Œ; n  15; p  0.05), because they were
superimposable on control values (‚). Ivermectin was applied 10 min before tetanic stimula-
tion (downward filled arrows); it did not change the baseline of field EPSP. Tetanic stimulation
(4 times at 100 Hz for 1 s) was applied at the upward open arrows. All data points are mean
SEM, for nmice. Control data points in A are the same as in B and C.
Figure 3. Contribution of P2X4 receptor activation to tetanus-induced LTP in hippocampal
CA1 pyramidal cells. A, The magnitude of LTP elicited by Schaffer collateral stimulation was
significantly reduced in P2X4
/mice (‚; n 12) compared with wild-type P2X4
/mice
Sim et al. • P2X4 Receptors and LTP J. Neurosci., August 30, 2006 • 26(35):9006–9009 • 9009
